150 related articles for article (PubMed ID: 37952515)
1. Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody.
Cyranka L; Mariegaard I; Skjødt MO; Bayarri-Olmos R; Mollnes TE; Garred P; Rosbjerg A
J Innate Immun; 2023; 15(1):836-849. PubMed ID: 37952515
[TBL] [Abstract][Full Text] [Related]
2. Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.
Karasu E; Demmelmaier J; Kellermann S; Holzmann K; Köhl J; Schmidt CQ; Kalbitz M; Gebhard F; Huber-Lang MS; Halbgebauer R
Front Immunol; 2020; 11():1789. PubMed ID: 32983087
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM
Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759
[TBL] [Abstract][Full Text] [Related]
4. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
5. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
Sadik CD; Miyabe Y; Sezin T; Luster AD
Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
7. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
[TBL] [Abstract][Full Text] [Related]
8. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
Carvelli J; Demaria O; Vély F; Batista L; Chouaki Benmansour N; Fares J; Carpentier S; Thibult ML; Morel A; Remark R; André P; Represa A; Piperoglou C; ; ; Cordier PY; Le Dault E; Guervilly C; Simeone P; Gainnier M; Morel Y; Ebbo M; Schleinitz N; Vivier E
Nature; 2020 Dec; 588(7836):146-150. PubMed ID: 32726800
[TBL] [Abstract][Full Text] [Related]
9. Discovery and Characterization of a New Class of C5aR1 Antagonists Showing
Hubler F; Renneberg D; Siendt H; Stamm S; Hilpert K; Caroff E; Delahaye S; Froidevaux S; Murphy MJ
J Med Chem; 2024 Mar; 67(5):4100-4119. PubMed ID: 38482828
[TBL] [Abstract][Full Text] [Related]
10. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
Elsner J; Oppermann M; Kapp A
Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
[TBL] [Abstract][Full Text] [Related]
11. Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages.
Wu KC; Condon ND; Hill TA; Reid RC; Fairlie DP; Lim J
J Innate Immun; 2023; 15(1):468-484. PubMed ID: 36882040
[TBL] [Abstract][Full Text] [Related]
12. C5a-C5aR1 Axis Activation Drives Envenomation Immunopathology by the Snake
Silva de França F; Villas-Boas IM; Cogliati B; Woodruff TM; Reis EDS; Lambris JD; Tambourgi DV
Front Immunol; 2021; 12():652242. PubMed ID: 33936074
[TBL] [Abstract][Full Text] [Related]
13. The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells.
Wiese AV; Ender F; Quell KM; Antoniou K; Vollbrandt T; König P; Köhl J; Laumonnier Y
PLoS One; 2017; 12(9):e0184956. PubMed ID: 28931049
[TBL] [Abstract][Full Text] [Related]
14. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
Gorman DM; Li XX; Lee JD; Fung JN; Cui CS; Lee HS; Rolfe BE; Woodruff TM; Clark RJ
J Med Chem; 2021 Nov; 64(22):16598-16608. PubMed ID: 34762432
[TBL] [Abstract][Full Text] [Related]
15. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.
Pandey S; Li XX; Srivastava A; Baidya M; Kumari P; Dwivedi H; Chaturvedi M; Ghosh E; Woodruff TM; Shukla AK
J Biol Chem; 2019 Jun; 294(24):9416-9429. PubMed ID: 31036565
[TBL] [Abstract][Full Text] [Related]
16. C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.
Zheng QY; Liang SJ; Xu F; Li GQ; Luo N; Wu S; Li Y; Tang M; Zhong Y; Chen J; Yang D; Sun DD; Zhang KQ; Xu GL
Front Immunol; 2019; 10():1866. PubMed ID: 31447855
[TBL] [Abstract][Full Text] [Related]
17. C5a-C5AR1 axis as a potential trigger of the rupture of intracranial aneurysms.
Okada A; Shimizu K; Kawashima A; Kayahara T; Itani M; Kurita H; Miyamoto S; Kataoka H; Aoki T
Sci Rep; 2024 Feb; 14(1):3105. PubMed ID: 38326494
[TBL] [Abstract][Full Text] [Related]
18. Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1
Wang HA; Lee JD; Lee KM; Woodruff TM; Noakes PG
Skelet Muscle; 2017 Jun; 7(1):10. PubMed ID: 28571586
[TBL] [Abstract][Full Text] [Related]
19. Netrin-1 Reduces Monocyte and Macrophage Chemotaxis towards the Complement Component C5a.
Taylor L; Brodermann MH; McCaffary D; Iqbal AJ; Greaves DR
PLoS One; 2016; 11(8):e0160685. PubMed ID: 27509208
[TBL] [Abstract][Full Text] [Related]
20. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.
Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE
Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
